Related Experiment Video

Updated: Feb 7, 2026

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.7K

Heterogeneous Responses of Ovarian Cancer Cells to Silver Nanoparticles as a Single Agent and in Combination with

Cale D Fahrenholtz1, Jessica Swanner1, Maria Ramirez-Perez2

  • 1Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.

Journal of Nanomaterials
|July 24, 2018
PubMed

Insights

Silver nanoparticles (AgNPs) show differential cytotoxicity in ovarian cancer cells, inducing DNA damage and reactive oxygen species (ROS) in sensitive cell lines. AgNPs synergize with cisplatin, offering potential for ovarian cancer treatment.

Area of Science:

  • Nanomedicine
  • Cancer Biology
  • Toxicology

Background:

  • Ovarian cancer remains a leading cause of cancer-related deaths globally.
  • Developing novel therapeutic strategies is crucial for improving patient outcomes.
  • Silver nanoparticles (AgNPs) have emerged as potential anticancer agents due to their unique properties.

Purpose of the Study:

  • To investigate the cytotoxic effects of AgNPs on different ovarian cancer cell lines.
  • To elucidate the mechanisms underlying AgNP-induced cytotoxicity, including DNA damage and reactive oxygen species (ROS) generation.
  • To evaluate the synergistic potential of combining AgNPs with cisplatin, a standard chemotherapeutic agent.

Main Methods:

  • Exposure of three ovarian cancer cell lines (A2780, SKOV3, OVCAR3) to varying concentrations of AgNPs.
  • Assessment of cell viability, DNA damage, and intracellular ROS levels.
  • Investigation of the role of particle uptake versus silver ion toxicity.
  • Combination studies with cisplatin (CDDP) to evaluate synergistic effects and dose reduction.

Main Results:

  • AgNPs exhibited significant cytotoxicity towards A2780 and SKOV3 cells, but less sensitivity in OVCAR3 cells.
  • AgNP exposure induced DNA damage and increased ROS levels in sensitive cell lines (A2780, SKOV3), correlating with basal ROS levels.
  • Cytotoxicity was attributed to intact AgNP uptake, not silver ion sensitivity.
  • Combination therapy with AgNPs and cisplatin demonstrated synergistic effects in A2780 and OVCAR3 cells, with a favorable dose reduction across all tested cell lines.

Conclusions:

  • Ovarian cancer cell lines display heterogeneous responses to AgNP exposure, linked to basal ROS levels and particle uptake.
  • AgNPs possess intrinsic anticancer properties and can enhance the efficacy of conventional chemotherapy.
  • The synergistic interaction between AgNPs and cisplatin suggests a promising therapeutic strategy for ovarian cancer treatment, potentially reducing chemotherapy dosage and side effects.

More Related Videos

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines11:50

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines

Published on: September 10, 2014

13.9K
Quantifying Replication Stress in Ovarian Cancer Cells Using Single-Stranded DNA Immunofluorescence06:25

Quantifying Replication Stress in Ovarian Cancer Cells Using Single-Stranded DNA Immunofluorescence

Published on: February 10, 2023

2.5K

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.9K
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
4.1K
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
580
Diversity in Cell Signaling Responses01:22

Diversity in Cell Signaling Responses

The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity. 
Graded and Abrupt Responses
Some signaling systems generate...
8.0K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
84.2K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.9K